FierceBiotech Jan 20, 2026 Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
FierceBiotech Jan 20, 2026 Boundless finally gives up on combo treatment of 2 unimpressive cancer drugs
FierceBiotech Jan 20, 2026 Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis
FierceBiotech Jan 20, 2026 Tanabe Pharma's oral drug scores in ph. 3 rare disease study, though details remain in the dark
FierceBiotech Jan 20, 2026 Pfizer pens $530M deal to use Novavax's vaccine adjuvant tech on 2 programs
Illumina Jan 20, 2026 Optimizing Illumina Long-Read Whole Genome Sequencing of Salivary DNA Using Oragene™ Collection Devices - the-scientist.com